Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Grau

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 27, 2021
[Brain metastases-Interdisciplinary approach towards a personalized treatment]S Grau, M Herling, C Mauch, et al.
International Journal of Antimicrobial Agents|September 3, 2019
Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative studyD Echeverria-Esnal, L Sorli, N Prim, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 29, 2015
Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patientsS Grau, J C Pozo, E Romá, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also Known as Clostridium Difficile-Associated Diarrhoea (CDAD) in SpainJ Cobo Reinoso, S Grau Cerrato, J Mensa Pueyo, et al.
International Journal of Antimicrobial Agents|November 10, 2021
Corrigendum to "Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative study" [International Journal of Antimicrobial Agents, Volume 54, Issue 5 (2019) 572-578]D Echeverria-Esnal, L Sorli, N Prim, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2016
Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal InfectionA García-de-Lorenzo, S Luque, S Grau, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|May 30, 2008
[Levofloxacin in the treatment of nosocomial infection in critically ill patients]F Alvarez Lerma, J L Romero Luján, A Morón Jiménez, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 19, 2005
[Economic evaluation of voriconazole versus amphotericin B in the treatment of invasive aspergilosis]S Grau Cerrato, J Mateu-de Antonio, J Soto Alvarez, et al.
Medicina Intensiva|August 10, 2014
Degree of adherence to recommended antiviral treatment during the pandemic and post-pandemic periods of influenza A(H1N1)pdm09 in 148 intensive care units in SpainL Canadell, I Martín-Loeches, E Díaz, et al.
The Journal of Antimicrobial Chemotherapy|July 17, 2015
Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitisS Grau, S Luque, N Campillo, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 27, 2021
[Brain metastases-Interdisciplinary approach towards a personalized treatment]S Grau, M Herling, C Mauch, et al.
International Journal of Antimicrobial Agents|September 3, 2019
Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative studyD Echeverria-Esnal, L Sorli, N Prim, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 29, 2015
Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patientsS Grau, J C Pozo, E Romá, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also Known as Clostridium Difficile-Associated Diarrhoea (CDAD) in SpainJ Cobo Reinoso, S Grau Cerrato, J Mensa Pueyo, et al.
International Journal of Antimicrobial Agents|November 10, 2021
Corrigendum to "Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative study" [International Journal of Antimicrobial Agents, Volume 54, Issue 5 (2019) 572-578]D Echeverria-Esnal, L Sorli, N Prim, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2016
Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal InfectionA García-de-Lorenzo, S Luque, S Grau, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|May 30, 2008
[Levofloxacin in the treatment of nosocomial infection in critically ill patients]F Alvarez Lerma, J L Romero Luján, A Morón Jiménez, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 19, 2005
[Economic evaluation of voriconazole versus amphotericin B in the treatment of invasive aspergilosis]S Grau Cerrato, J Mateu-de Antonio, J Soto Alvarez, et al.
Medicina Intensiva|August 10, 2014
Degree of adherence to recommended antiviral treatment during the pandemic and post-pandemic periods of influenza A(H1N1)pdm09 in 148 intensive care units in SpainL Canadell, I Martín-Loeches, E Díaz, et al.
The Journal of Antimicrobial Chemotherapy|July 17, 2015
Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitisS Grau, S Luque, N Campillo, et al.
Pageof 13